EPHA3, EPH receptor A3, 2042

N. diseases: 193; N. variants: 18
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.090 AlteredExpression disease BEFREE In this study, using radioligand binding assay, immunoblot or immunocytochemistry methods, we observed that SK608 induced internalization of human D3R stably expressed in CHO, HEK and SH-SY5Y cells which are derived from neuroblastoma cells, suggesting that it is not a cell-type specific event. 30844536 2019
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.090 Biomarker disease BEFREE It showed cytotoxicity to neuroblastoma (SHSY5Y) cell line with IC<sub>50</sub> value < 100 μg ml<sup>- 1</sup> but had least damaging effect on normal cells, like human embryonic kidney (HEK-293) and liver (WRL-68) cell lines. 31382946 2019
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.090 Biomarker disease BEFREE Moreover, in transfected HEK-293T and neuroblastoma SH-SY5Y cells, and in primary neuronal cultures, pretreatment with cocaine or a σ<sub>1</sub>R agonist inhibited ghrelin-mediated signaling, in a similar manner as the GHS-R1a antagonist YIL-781. 29876881 2019
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.090 Biomarker disease BEFREE Here we studied vortioxetine's functional effects across species (canine, mouse, rat, guinea pig and human) in cellular assays with heterologous expression of 5-HT<sub>3A</sub> receptors (in Xenopus oocytes and HEK-293 cells) and in mouse neuroblastoma N1E-115 cells with endogenous expression of 5-HT<sub>3A</sub> receptors. 29274875 2018
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.090 Biomarker disease BEFREE Our observations show that HS-2015-BA-01 is more cytopathic than PLCal_ZV in proliferation assays in Vero, Human Embryonic Kidney HEK 293T and neuroblastoma SH-SY5Y cells. 29382068 2018
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.090 GeneticVariation disease BEFREE In this study, we analyzed the functional implication of this mutation in the human neuroblastoma cell line BE(2)-C, and non-neural Human Embryonic Kidney 293 (HEK-293), and show that the -220A mutation results in a constitutive increase in the expression of the CALR gene (p<0.0003). 21723904 2011
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.090 GeneticVariation disease BEFREE SK-N-SH (neuroblastoma) and PC-12 (phaeochromocytoma) cells were used and compared with HEK-293 cells transfected with OCT1, OCT2 and OCT3, respectively. 19324274 2009
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.090 Biomarker disease BEFREE We addressed the importance of the DAT molecule for selective dopaminergic toxicity by testing the differential cytotoxicity of 22 neutral and quaternary compounds from three classes of isoquinoline derivatives (3, IQs; 4,3,4-dihydroisoquinolines and 15, 1,2,3,4-tetrahydroisoquinolines) as well as MPP(+) in non-neuronal and neuronal heterologous expression systems of the DAT gene (human embryonic kidney HEK-293 and mouse neuroblastoma Neuro-2A cells, respectively). 11911843 2002
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.090 Biomarker disease BEFREE We compared the subcellular localization of FLAG-epitope tagged Types 1 and 2 deiodinases (D1 and D2) transiently expressed in human embryonic kidney (HEK-293) and mouse neuroblastoma (NB2A) cells. 11089566 2000